🫘🦋Newer Therapies in Lupus Nephritis kidneymedicinejournal.org/article/S2590-…

Now published simultaneously in AC&R + A&R, the 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis See ACR guideline page for resources - rheumatology.org/lupus-guideline DOI link - doi.org/10.1002/acr.25… Download the article - acr.tw/44sRwJM

En diabetes, enfermedad renal crónica y alto riesgo de progresión, hagamos lo posible por iniciar los 4 pilares del tratamiento rápidamente, es decir en 2-3 semanas, e ir evaluando su seguridad El mayor beneficio a quienes más lo ameritan JASN 2025 DOI: 10.1681/ASN.0000000752

Inicio temprano de los 4 pilares de la enfermedad renal crónica 🍀 ✅se ha visto que el uso de los 4 fármacos disminuye la progresión de la enfermedad renal en pacientes con diabetes mellitus tipo 2 ✅titulación de los fármacos: ARM (finerenona), GLP1, RASi e ISGLT2

🔥Diabetic Kidney Disease by Drs. Juan F. Navarro and Jose Luis Górriz Jose Luis Górriz #NephSAP American Society of Nephrology ASN Publications nephsap.org/view/journals/… 🔥Lo último en ERD ahora también en vídeo durante la Reunión de Grupo #GEENDIAB, explicado por los autores: youtube.com/watch?v=dAwwOl…

Do you know how best to apply guidelines for treating and managing patients with CKD and T2D? In this free KDIGO-Medscape CME activity, Dr. Janani Rangaswami and Dr. Abhinav Sharma provide expert guidance on: - Screening with eGFR and albuminuria - Applying current treatment

Hypothyroid and kidneys

Síndrome Cardiovascular-Reno-Metabólico. Plática 14/05/2025. Para repasar, dejo aquí algunas de las diapositivas...

The role of finerenone in the concomitant management of CKD-type 2 diabetes and the implication for HF prevention and treatment finerenone presents new evidence-based therapy for HFpEF/HFmrEF in addition to current application in CKD associated with T2D link.springer.com/article/10.100…

Switching from sMRA to Finerenone in patients with CKD and Type 2 diabetes: Patients in treatment with spironolactone/eplerenone showed a significant reduction in serum potassium at 3 months when switched to finerenone. No changes in serum creatinine

Last presentation during LBCTII #ERA25 📍Mineralocorticoid receptor antagonists in patients with kidney failure receiving dialysis: an updated systematic review and meta-analysis 🎙️Lonnie Pyne Lonnie Pyne

How to manage combinations in real world clinical practice ? #ERA25 #wien ERA - European Renal Association

Optimizing the timing and sequencing of guideline-directed medical therapy for T2D and CKD ca. 2024 from Brendon Neuen Katherine Tuttle george bakris George Bakris Muthu Vaduganathan #ERA25 🇦🇹 #Nephpearls #Cardiorenal 👉 pubmed.ncbi.nlm.nih.gov/40179265/

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) The ongoing EASI-KIDNEY study is evaluating the combination of an SGLT2 inhibitor and an aldosterone synthase inhibitor on CV and renal outcomes in CKD

Why is it important to measure UACR? Albuminuria predicts risk of incident HF Up to 2.7x risk of incident HF Albuminuria in progression of HF UACR was a strong independent predictor of adverse prognosis in HF irrespective of hypertension or T2D

🚨 Cardiorenal Syndrome (CRS): A Deadly Duo 🚨 Did you know the heart & kidneys are so intertwined that dysfunction in one can wreak havoc on the other? Let's dive into CRS today. A lucid read for every nephrology & cardiology fellow 🫀🩺 #MedTwitter #ISNTweetorial

¿Conoces el proyecto #ERCAnews de los GdT JovSEN y #ERCA? 🚀3 webinars que te traen lo + destacado en enfermedad renal crónica avanzada ▶️Accede a todos los recursos en: senefro.org/modules.php?na… Novo Nordisk España CSL Vifor ES

Genetics in Glomerular Diseases ca. 2025 from Janewit Wongboonsin, MD, MS #GKHSummit25 🧬 #Nephpearls #KDIGOGeneticsinCKD 🧬 👉 pubmed.ncbi.nlm.nih.gov/40664524/om

APOL1 mediated kidney disease (AMKD): Clinical approach to genetic testing ca. 2025 from Kidney Medicine Nasim Wiegley, MD, FASN Paolo Nikolai So Edward Kwakyi GlomCon #GKHSummit25 🧬 #Nephpearls #KDIGOGeneticsinCKD 🧬 👉 pubmed.ncbi.nlm.nih.gov/40837248/